E-LIB Suche - Ergebnisse für: Zhu, Feng-Cai

1

Immunogenicity and safety of an ORF7-deficient skin-attenua..:

Pan, Hong-Xing ; Qiu, Ling-Xian ; Liang, Qi...
The Lancet Infectious Diseases. , 2024

Link: https://doi.org/10.1016/..

2

The era of SARS-CoV-2 variants calls for an urgent strategy..:

Li, Si-Min ; Zhu, Feng-Cai
The Lancet Infectious Diseases. 24 (2024) 7 - p. 666-667 , 2024

Link: https://doi.org/10.1016/..

3

A China-developed adenovirus vector-based COVID-19 vaccine:..:

Wang, Shen-Yu ; Liu, Wen-Qing ; Li, Yu-Qing..
Expert Review of Vaccines. 22 (2023) 1 - p. 704-713 , 2023

Link: https://doi.org/10.1080/..

4

Immunogenicity and safety of heterologous immunisation with..:

Jin, Peng-Fei ; Guo, Xi-Ling ; Gou, Jin-Bo...
The Lancet Regional Health - Western Pacific. 38 (2023) - p. 100829 , 2023

Link: https://doi.org/10.1016/..

5

Environmental Impact Assessment for the Use of an Orally Ae..:

Xia, Xin ; Tan, Zhong-Ming ; Wan, Peng...
The Journal of Infectious Diseases. 228 (2023) 6 - p. 715-722 , 2023

Link: https://doi.org/10.1093/..

6

Head-to-head immunogenicity comparison of an Escherichia co..:

Zhu, Feng-Cai ; Zhong, Guo-Hua ; Huang, Wei-Jin...
The Lancet Infectious Diseases. 23 (2023) 11 - p. 1313-1322 , 2023

Link: https://doi.org/10.1016/..

7

Safety and immunogenicity of a modified COVID-19 mRNA vacci..:

Gui, Yu-Zhou ; Li, Xue-Ning ; Li, Jing-Xin...
eBioMedicine. 91 (2023) - p. 104586 , 2023

Link: https://doi.org/10.1016/..

8

Immunogenicity consistency and safety with different produc..:

Wu, Yan-Fei ; Wei, Ming-Wei ; Wang, Rui-Jie...
Expert Review of Vaccines. 22 (2023) 1 - p. 662-670 , 2023

Link: https://doi.org/10.1080/..

9

Comparison of antibody persistency through one year between..:

Feng, Jia-Lu ; Wang, Wen-Juan ; Jin, Peng-Fei...
Human Vaccines & Immunotherapeutics. 19 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

10

Efficacy of SARS-CoV-2 vaccines and the dose–response relat..:

Yang, Zhi-Rong ; Jiang, Yi-Wen ; Li, Fu-Xiao...
The Lancet Microbe. 4 (2023) 4 - p. e236-e246 , 2023

Link: https://doi.org/10.1016/..

11

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
The Lancet Regional Health - Western Pacific. 34 (2023) - p. 100731 , 2023

Link: https://doi.org/10.1016/..

12

Evaluation of a recombinant five-antigen Staphylococcus aur..:

Zhu, Feng-Cai ; Zeng, Hao ; Li, Jing-Xin...
Vaccine. 40 (2022) 23 - p. 3216-3227 , 2022

Link: https://doi.org/10.1016/..

13

Batch-to-batch consistency trial of an adenovirus type-5 ve..:

Li, Zhuo-Pei ; Shi, Yun-Feng ; Hou, Li-Hua...
Expert Review of Vaccines. 21 (2022) 12 - p. 1843-1849 , 2022

Link: https://doi.org/10.1080/..

14

Immunogenicity and safety of human diploid cell vaccine (HD..:

Wang, Shi-Yuan ; Sun, Jin-Fang ; Liu, Pei...
Human Vaccines & Immunotherapeutics. 18 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

15

Head-to-head comparisons of the neutralizing antibody again..:

Jiang, Hu-Dachuan ; Guo, Xi-ling ; Jin, Peng-Fei...
Emerging Microbes & Infections. 11 (2022) 1 - p. 1751-1753 , 2022

Link: https://doi.org/10.1080/..